Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 22.62 |
| Open | 22.72 |
| Bid | 23.07 x 100 |
| Ask | 23.17 x 300 |
| Day's Range | 22.66 - 23.84 |
| 52 Week Range | 20.67 - 42.48 |
| Volume | |
| Avg. Volume | 1,286,221 |
| Market Cap | 2.871B |
| Beta (5Y Monthly) | 0.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses
Key Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock price is sensitive to...
- GuruFocus.com
Insider Sell: Chief Discovery/Trans Medicine James Hamilton Sells 6,000 Shares of Arrowhead ...
James Hamilton, Chief Discovery and Translational Medicine Officer at Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 6,000 shares of the company on April 1, 2024, according to a recent SEC filing.
- GuruFocus.com
Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Shares
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CFO Kenneth Myszkowski sold 40,000 shares of the company's stock on March 6, 2024, according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.